April 2022

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company located in Hyderabad, Telangana, India. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited.

Nectar Lifesciences Ltd. is a fast growing Rs.3000 Crores Turnover Company engaged in manufacturing and marketing of API (Oral & Sterile), Formulations and Phytochemicals, having Global positions in API's & Menthol. The Company is poised to make rapid strides in all areas of its business activities.

Globally renowned, vertically integrated pharmaceutical player engaged in Research and Development (R&D), manufacturing, and marketing of high-quality chemical and biologic medicines across diverse therapeutic areas.

Department : Quality Control

SMS Pharmaceuticals Ltd. is a global player in API manufacturing having a strong research and manufacturing team supported by state of the art facilities. What started off as a single facility single product manufacturing company in 1990 grew to be a multi-location group having product list spreading across an array of therapeutic segments. SMS was given the export house status in the year 1997-98. SMS is currently a listed company having ever appreciating international and domestic customer base.

Akums Drugs & Pharmaceuticals Ltd. India is an internationally recognized WHO-GMP certified and one of the leading contract manufacturing pharmaceutical company. Akums has rapidly emerged as the premier integrated pharmaceutical company in India. Its business focus is on manufacturing & marketing of pharmaceutical products along with serving clients across the globe.

Alkem Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra, India that manufactures and sells pharmaceutical generics, formulations and nutraceuticals in India and globally.

Position / Exp : Executive / Sr. Officer / Officer

Qualification : M.Pharm / B.Pharm / M.Sc

Experience : 2 to 6 years

Novartis announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval to Vijoice (alpelisib) for the treatment of adult and pediatric patients 2 years of age and older with severe manifestations of PIK3CA-Related Overgrowth Spectrum (PROS) who require systemic therapy. Vijoice is the first FDA-approved treatment for PROS, a spectrum of rare conditions characterized by overgrowths and blood vessel anomalies impacting an estimated 14 people per million.

Saladax Biomedical, Inc. (Saladax) is pleased to announce that it has acquired a patent portfolio for antipsychotic drug testing from Janssen Pharmaceutica NV. This intellectual property (IP) portfolio includes 17 patent families and has resulted in 33 U.S. patents and 296 patents in ex-U.S. countries. This IP, along with the current Saladax IP, covers the major antipsychotic drugs that are prescribed worldwide and places Saladax in a premier position in the antipsychotic drug testing field.

Central Council for Research in Homoeopathy is an apex research organization under Ministry of AYUSH, Govt. of India which undertakes, coordinates, develops, disseminates and promotes scientific research in Homoeopathy.